Salazar Ryan D, Weidner Krystol R, Alquist Caroline R
University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Hoxworth Blood Center, University of Cincinnati, Cincinnati, Ohio, USA.
J Clin Apher. 2024 Feb;39(1):e22098. doi: 10.1002/jca.22098. Epub 2023 Nov 21.
Susac's syndrome (SuS) is an autoimmune endotheliopathy that typically presents with the clinical triad of encephalopathy, hearing loss, and branch retinal artery occlusion. It has a wide range of possible presentations, and its pathogenesis remains uncertain. Fulminant and refractory cases are difficult to treat, and no standard treatment protocol has been established. However, therapeutic plasma exchange (TPE) has been described as an adjunctive therapy in several SuS cases. Herein we present a case of a 63-year-old male with debilitating encephalopathy and recent hearing and vision loss, who responded favorably to TPE. Given this and other published reports of plasma exchange therapy for SuS, treatment protocols should consider TPE in early stages of disease.
苏萨克综合征(SuS)是一种自身免疫性内皮病变,通常表现为脑病、听力丧失和视网膜分支动脉阻塞的临床三联征。它有多种可能的表现形式,其发病机制仍不明确。暴发性和难治性病例难以治疗,尚未建立标准的治疗方案。然而,治疗性血浆置换(TPE)在几例苏萨克综合征病例中已被描述为一种辅助治疗方法。在此,我们报告一例63岁男性患者,患有使人衰弱的脑病以及近期出现听力和视力丧失,该患者对TPE治疗反应良好。鉴于此病例以及其他已发表的关于血浆置换疗法治疗苏萨克综合征的报告,治疗方案应在疾病早期考虑采用TPE。